Navigation Links
Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors
Date:5/11/2009

with espionage in the trial of Saberi, Iran has equated public health diplomacy with treason in the case of the Alaeis. This is a terribly dangerous stance in an era of global pandemics which require open medical collaboration to save lives," said Kalloch.

"The Alaeis are on their final appeal. Health workers and human rights advocates from 129 countries have signed a petition calling for their release. It's time for Iran to stand up and protect freedom of science--and the lives of Iranians--by releasing the Alaeis," said Jonathan Hutson, Chief Communications Officer at Physicians for Human Rights.

In January, Dr. Kamiar Alaei and his brother Dr. Arash Alaei were sentenced to prison terms of three and six years, respectively, in Tehran's notorious Evin Prison. At no point has the Iranian prosecutor made public any shred of evidence to support his contention that the brothers were involved in any international activity other than the fight against global AIDS.

According to sources close to the Alaei brothers' case, the appellate court received their appeals on March 17 and the following day - without a hearing - summarily rejected their appeals and upheld their sentences.

Their attorney, Massoud Shaffiie filed a final appeal on May 7 to Iran's judiciary chief Ayatollah Mahmoud Hashemi Shahrudi under Article 118 of the Iranian Constitution.

"The case of these world-renowned HIV/AIDS physicians is part of a crackdown on international scientific and academic exchange which undermines efforts of all who seek to treat global AIDS and protect the health of the Iranian people. Their imprisonment robs the world of two talented physicians and has a chilling effect on public health dialogue and diplomacy worldwide," Hutson said. "It appears that the jailing of people on trumped-up charges has more to do with appeasing the conservatives in advance of Iran's national elections in June."

D
'/>"/>

Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Memry Corporation Announces Fiscal Fourth Quarter and 2007 Year End Earnings Release and Conference Call
2. Somanetics Corporation to Release Third Quarter 2007 Financial Results and Host Conference Call September 19
3. First New York/New Jersey Health Care Report Card Released
4. Cleveland Clinic Press Releases Journal-Writing Book Write for Life: Healing Body, Mind, and Spirit Through Journal Writing by Sheppard B. Kominars, Ph.D.
5. Robbins & Myers to Release Fourth Quarter and 2007 Fiscal Year Results on Monday, October 15, 2007
6. Leading Child Abuse Center Releases Back to School Tips to Protect Children From Internet Predators
7. Kensey Nash Corporation Announces its First Quarter 2008 Earnings Release Date and Teleconference
8. JHA Releases 2007 U.S. Group Disability Mid-Year Market Survey Results
9. Verdict One Releases Directory of Board Certified Attorneys for Consumers
10. Academy releases emergency preparedness tools to enable millions more people to shelter in place
11. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors
Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors
(Date:11/23/2009),, NEWYORK,Nov.23/PRNewswire/--Livingwithchronicpaincanbedifficult-andthestressoftheholidayseasoncanprovetobequitechallengingforthoselivingwithpain. ,, ListentothisreportfromPfizerInc.at: ,
(Date:11/23/2009)...ter suffering from women,s hair loss for almost te...d she,s sharing her progress and the secret behind... the release of her video diaries which include a ...r treatment. , (PRWeb UK)...er Zsanett Siklosi has released the video diaries ...
(Date:11/23/2009)...RNewswire-FirstCall/--InfoLogix,Inc.(Nasdaq: IFLG ...lutionsforthehealthcareandcommercialindustries,ann...ServicesatSiemensHealthServices,hasjoinedInfoLogix..., (Logo: http://www.newscom.com/cgi-bin/prnh/20090...HealthcareServicesforInfoLogix,Mr.Waywillberespons...
(Date:11/23/2009)...atients and survivors treated with chemotherapy su... chronic conditions, hindering patients, ability t...iversity of Rochester Medical Center. , A study ...ep troubles at nearly three times the rate of the ... in younger patients and those with lung and breas...
(Date:11/23/2009)...rop by 63 percent with moderate-to-high intensity ...News) -- Moderate-to-high intensity exercise such ...oke risk in older men but not in women, researcher... and women, average age 69, in Manhattan who were ...here were 238 strokes among the participants. At t...
Breaking Medicine News(10 mins):Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 2Health News:Women's Hair Loss Treatment Results Captured on Video to Inspire Others 3Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 2Health News:Jim Way, Former Vice President at Siemens Health Services, Joins InfoLogix, Inc. as Vice President of Strategic Healthcare Services 3Health News:Insomnia prevalent among cancer patients who receive chemotherapy 2Health News:Vigorous Exercise Cuts Stroke Risk for Men, Not Women 2
...ts have provided new details about how proteins us...Alzheimer's disease. Gunnar K. Gouras, as... Weill Medical College of Cornell University, New ... for a vaccine against the disease. "Antib...
...alf the central government funds allocated to figh...n southern states that, ironically, were strugglin...ected at least 1.4 million people across the count... help them contain the chikungunya fever. But a su...
...ll establish 30 world-class universities across th...country's entry into the knowledge economy, Prime... "This expansion is going to be a landmark in ...mong the top institutions in the world," the prime...
...must provide more flexible working, the BMA says t... that female doctors embarking on NHS careers outn...t of 435 doctors who graduated from UK medical sch...ed a similar study of medical graduates. This is i...
... with radiation retinopathy who were destined to g... longer through localized treatment with Avastin ,... study published in the June, 2007 Archives of Oph...thy, said Paul T. Finger, MD, lead author of the s...
...iction worldwide appears to be slowing down for al...s Office on Drugs and Crime said on Friday. "...uth of Afghanistan, a cancer that threatens secur.... "Furthermore, progress made in some countrie...
Other Medicine News:Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 2Health News:Researchers Link Bacteria Destroying Proteins to Alzheimer's Treatment 3Health News:Chikungunya Spreads as Funds Remain Unspent 2Health News:India to Have 30 World-class Universities Across the Country: PM 2Health News:BMA Calls for Flexible Working as Number of Women Doctors Swell 2Health News:Untreatable Eye Disease Improves With Avastin 2Health News:Drug Addiction Slowing Down: UN Report 2
(Date:11/23/2009)...3/PRNewswire/--TwooftheChicagoarea,sleadingBoardCe...inwomen,sbreastimaging,couplingthelatesttechnology...soundwiththeabilitytohavethefullrangeofdigitalimag...foresheleavestheoffice.Drs.AhmedFaragandJoanWerber...hecurrent6-9monthwaitforanappointmentcommonlyfound...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--NuVasive, Inc. (Nasdaq: ...ductsforminimallydisruptivesurgicaltreatmentsforth...hiefExecutiveOfficer,andMichaelJ.Lambert,Executive...topresentatthe21stAnnualPiperJaffrayHealthCareConf...day,December2,2009,at10:00a.m.ET.Mr.LukianovandMr....
(Date:11/23/2009)...Nov.23/PRNewswire-FirstCall/--Immucor,Inc.(Nasdaq:...t-reagentsystemstothebloodtransfusionindustry,toda...fray21stAnnualHealthCareConferenceinNewYork,NYwill...Company,spresentationisscheduledforTuesday,Decembe...tionwillbeavailablethroughthe"AboutUs--InvestorInf...
Breaking Medicine Technology:NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 2NuVasive To Present at the Piper Jaffray Health Care Conference and the J.P. Morgan SMid Cap Conference 32009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 12009 Pharma ChemOutsourcing Show Attendance Up an Astounding 60 25 Despite Current Recession 12440 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 1Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 2Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 3Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 4Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 5Peregrine Pharmaceuticals Highlights Promising Early Data From Its Three Phase II Bavituximab Cancer Trials 4527 6Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 1Global Decompression Announces C O D Available on All Used Axiom DRX 9000 Spinal Decompression Systems 47748 2
... Program for Oral Compounds,to Treat Alcohol Depe...2, 2007--Alkermes, Inc.,(Nasdaq: ALKS) today annou...trial of ALKS 29 in alcohol dependent patients. Ba...rward with its,development program for oral produc...is a combination of two agents with distinct,pharm...
...07 -- DOR BioPharma, Inc.,(OTCBB: DORB) ("DOR" or ...lts from testing of a multivalent form of its botu...lished in the journal,Infection and Immunity (Ravi...75, p. 3043 ). These results are the first that,de...valent vaccine,that is active by the mucosal route...
Other Medicine Technology:Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 2Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 3Alkermes Announces Positive Results from Phase 1/2 Clinical Study,of ALKS 29 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 2DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 3DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 4DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 5DOR BioPharma Announces Publication Describing Results of Its,Multivalent Botulinum Toxin Vaccine BT-VACC 6
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: